Frontline and Subsequent Therapies for Chronic Lymphocytic Leukemia

home / case-based-roundtable-series / frontline-and-subsequent-therapies-for-chronic-lymphocytic-leukemia

This roundtable series assesses the use of Bruton tyrosine kinase inhibition for patients with previously untreated or relapsed/refractory chronic lymphocytic leukemia, as discussed by participants at virtual live events.